5 FDA Decisions to Watch for Through June 2023
From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.
Source: hcplive.com
Page 11 - Published December News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Published December. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Published December Today - Breaking & Trending Today
Forecasting Real-World Usage of Lecanemab for AD Treatment: An Expert Roundtable
Clinicians discuss the risks and benefits and forecast the use of lecanemab for the treatment of AD in real-world clinical settings.
Source: clinicaladvisor.com
10 Years of SGLT2 Inhibitors: A Decade of Redefining Cardiometabolic Care
This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
Source: hcplive.com
Viral Vector Production Evolves to Meet Surging Demand
Vector manufacturers may tweak existing AAV systems, boost sheer capacity, and introduce novel host platforms to ensure delivery of gene therapies.
Source: genengnews.com
Migrants Have Lower Mortality Risk Than Long-term Manitobans
In Manitoba, Canada, international immigrants and interprovincial migrants had a mortality advantage, compared with long-term residents.
Source: medscape.com